Pashtoon Kasi, Medical Director of GI Medical Oncology at City of Hope Orange County, shared a post on X:
“AACR26
Looking forward to unveiling the first set of results on the phase-2 study!
We call it the CLOVER Trial.
- CCR5-targeting
- Leronlimab with
- Oral Chemotherapy and
- VEGF-inhibitor
- Enriched
- Regimen
Building upon options for our patients with Colorectal Cancer.
The fascinating part is how a drug ( Leronlimab) in latter phases of development for treatment of HIV is helping T-cells fight cancer.
Specifically focusing on pMMR/MSS ‘cold’.
Other articles featuring Pashtoon Kasi on OncoDaily.